01-04-2005 | ORIGINAL
A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot
Published in: Neurological Sciences | Issue 1/2005
Login to get access